Based on our meta-analysis, there has been a clear trend of benefit from postoperative adjuvant chemotherapy in patients with early-stage NSCLC, and some patients with stage IB NSCLC have already opted for postoperative adjuvant chemotherapy in the clinic.
← all excerpts
Meta-analysis of the efficacy of postoperative adjuvant chemotherapy for stage IB non-small cell lung cancer.
1
—
—